Original Research
Published on 14 Oct 2022
Exploring the druggability of the binding site of aurovertin, an exogenous allosteric inhibitor of FOF1-ATP synthase
in Experimental Pharmacology and Drug Discovery
- 3,491 views
- 4 citations
Original Research
Published on 14 Oct 2022
in Experimental Pharmacology and Drug Discovery
Original Research
Published on 13 Oct 2022
in Experimental Pharmacology and Drug Discovery
Original Research
Published on 13 Oct 2022
in Experimental Pharmacology and Drug Discovery
Original Research
Published on 13 Oct 2022
in Experimental Pharmacology and Drug Discovery
Original Research
Published on 13 Oct 2022
in Experimental Pharmacology and Drug Discovery
Original Research
Published on 13 Oct 2022
in Experimental Pharmacology and Drug Discovery
Review
Published on 13 Oct 2022
in Experimental Pharmacology and Drug Discovery
Original Research
Published on 13 Oct 2022
in Experimental Pharmacology and Drug Discovery
Editorial
Published on 12 Oct 2022
in Experimental Pharmacology and Drug Discovery
Review
Published on 12 Oct 2022
in Experimental Pharmacology and Drug Discovery
Original Research
Published on 12 Oct 2022
in Experimental Pharmacology and Drug Discovery
Original Research
Published on 12 Oct 2022
in Experimental Pharmacology and Drug Discovery
Mini Review
Published on 12 Oct 2022
in Experimental Pharmacology and Drug Discovery
Original Research
Published on 12 Oct 2022
in Experimental Pharmacology and Drug Discovery
Editorial
Published on 11 Oct 2022
in Experimental Pharmacology and Drug Discovery
Review
Published on 11 Oct 2022
in Experimental Pharmacology and Drug Discovery